A HER3-targeting antibody-drug conjugate for leptomeningeal metastasis.
Publication
, Journal Article
Anders, CK; Bansal, R; Van Swearingen, AED
Published in: Nat Med
August 2025
Duke Scholars
Published In
Nat Med
DOI
EISSN
1546-170X
Publication Date
August 2025
Volume
31
Issue
8
Start / End Page
2494 / 2495
Location
United States
Related Subject Headings
- Immunology
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Anders, C. K., Bansal, R., & Van Swearingen, A. E. D. (2025). A HER3-targeting antibody-drug conjugate for leptomeningeal metastasis. Nat Med, 31(8), 2494–2495. https://doi.org/10.1038/s41591-025-03853-x
Anders, Carey K., Rani Bansal, and Amanda E. D. Van Swearingen. “A HER3-targeting antibody-drug conjugate for leptomeningeal metastasis.” Nat Med 31, no. 8 (August 2025): 2494–95. https://doi.org/10.1038/s41591-025-03853-x.
Anders CK, Bansal R, Van Swearingen AED. A HER3-targeting antibody-drug conjugate for leptomeningeal metastasis. Nat Med. 2025 Aug;31(8):2494–5.
Anders, Carey K., et al. “A HER3-targeting antibody-drug conjugate for leptomeningeal metastasis.” Nat Med, vol. 31, no. 8, Aug. 2025, pp. 2494–95. Pubmed, doi:10.1038/s41591-025-03853-x.
Anders CK, Bansal R, Van Swearingen AED. A HER3-targeting antibody-drug conjugate for leptomeningeal metastasis. Nat Med. 2025 Aug;31(8):2494–2495.
Published In
Nat Med
DOI
EISSN
1546-170X
Publication Date
August 2025
Volume
31
Issue
8
Start / End Page
2494 / 2495
Location
United States
Related Subject Headings
- Immunology
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences